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ABSTRACT 
Objective: the present work aimed to synthesize novel quinoline and pyrroloquinoline derivatives and study their cytotoxic activity.  
Methods: Diels–Alder reaction (4+2) was used for the synthesis of new quinolone and pyrrolo quinoline derivatives via the reactions of compound 
1 with N-maleimide (4a-d) derivatives, ethyl acrylate (6) methylmethacrylate (8) and acetylene dicarboxylic acid (10). The synthesized compounds 
were characterized by NMR and Mass spectral data. Some of the synthesized compounds were screened for their antitumor activity against three 
different cell lines (MCF-7, HepG2 and HCT). 
Results: The tested compounds exhibited antiproliferative activity against the three different cell lines, especially against MCF-7. 
Conclusion: New quinoline and pyrroloquinoline derivatives were synthesized starting with 6-methyl-4-phenyl-2-thioxo-5-(4-methylphenylthio)-
1,2-dihydropyridine-3-carbonitrile. Two new compounds 3 and 5a were tested for their in vitro antiproliferative activity against MCF-7, HepG2 and 
HCT cancer cell lines. The result showed that compound 3 exhibited more potent antiproliferative activity than compound 5a in case of MCF-7 and 
HCT cell lines. 
Keywords: Quinolones, Pyrroloquinolines, Cycloaddition, Anti-tumor cytotoxicity. 
 
INTRODUCTION 
It is known that cancer is one of the most dangerous diseases, 
caused by uncontrolled growth and spread of abnormal cells, 
initiated by viruses, smoking, chemicals, or diet [1]. Cancer can lead 
to death if left untreated. Therefore, many of the research efforts aim 
to develop new anticancer drugs [2]. 
Quinoline and their derivatives are very important in medicinal 
chemistry because of their wide occurrence in natural products [3] 
and drugs[4], numerous quinolone derivatives [5-9] have been 
reported to have wide biological activities including the anticancer 
activity depending on various mechanisms like tubulin inhibition 
[10], free radical regulation and so on [11-13].  
And also, some natural, semisynthetic and synthetic bioactive 
molecules based on a quinoline scaffold had been reported to 
possess MDR reversal activity when combined with the anticancer 
drug [14-18], For example, the molecules containing quinolone 
scaffold improved the cytotoxicity of doxorubicin in multi-drug 
resistant cancer cell lines at nontoxic concentration [14]. 
Recently, a growing attention focuses on the synthesis and study of 
the biological properties of compounds containing various 
combinations of pyrroloquinoline moieties as remarkable cytotoxic 
agents [19-21]. Moreover, one class of marine alkaloids containing a 
pyrrole [3, 2-d] quinoline skeleton has received increasing attention 
as a source of new anticancer drugs [22, 23]. 
On the other hand, maleimide is among the best candidates for 
conjugation chemistry since it undergoes [4+2] cyclo addition 
reaction with electron rich dienes. The use of dienophile from 
hetero aromatic N-maleimide, electron-deficient acetylenes and 
ethylene as 1,2-dipoles has received increasing interest in the 
synthesis of new condensed heterocyclic structures via 4+2 cyclo 
addition [24-26]. 
The aforementioned studies encouraged us to prepare new 
quinolone and pyrroloquinoline derivatives via one pot Diels-Alder 
reaction and examine their antiproliferative activity in vitro against 
three human cancer cell lines. 
MATERIALS AND METHODS 
General 
All melting points were measured on a Gallenkamp melting point 
apparatus and are uncorrected. The IR spectra were recorded (KBr disk) 
on a Shimadzu FT IR-8201 PC instrument. 1H NMR spectra (300 MHz) 
spectra were recorded on a Varian spectrometer using DMSO-d6 or 
CDCl3 as solvent and TMS as an internal standard. Chemical shifts are 36 
reported in ppm. Mass spectra were recorded on a Shimadzu GCMS-
QP1000EX using inlet type at 70 ev. Elemental analyses were obtained 
from The Microanalytical Data Center at Cairo University, Egypt. The 
progress of the reactions was monitored by thin-layer chromatography 
(TLC) using aluminum sheets coated with silica gel F254 (Merck), 
viewing under a short-wavelength UV 41 lamp effected detection. All 
evaporations were carried out under reduced pressure at 40 oC. 6-
Methyl-4-phenyl-2-thioxo-5-(4-methylphenylthio)-1,2-dihydropyridine-
3-carbonitrile (1) was prepared according to the literature [27]. 
Synthesis 
6-[2-(4-chlorophenyl) viny]-4-phenyl-5(4-methylphenylthio)-2-
thioxo-1, 2-dihydro pyridine-3-carbonitrile (3) 
A solution of compound 1 (0.01 mole, 3.48 gm) and 4-
chlorobenzaldhyde (0.01 mole, 1.405 gm) in absolute ethanol (30 
ml) was heated under reflux for 8 h, then cooled and the solid was 
collected by filtration and crystallized from dioxane.  
Yellow crystals (70%); m. p. 230-2 oC; 1H NMR(DMSO-d6) δ=2.28 (s, 
3H, tolyl-CH3), 4.14 (br, 1H, NH), 6.74-7.49 ppm (m, 15H, Ar-H and 
CH=CH); MS (70 eV): m/z = 471 (M++1, 8.55), 470(M+,100) 348 (17.8), 
301 (9.6), 285 (8.28), 269 (12.8), 226 (67.29), 154 (57), 77 (64), 140 
(52), 113 (56.6); Anal. Calcd. for C27H19ClN2S2 (470): C, 68.85; H, 4.07; 
N, 5.95; S, 13.61. Found: C, 68.87; H, 4.08; N, 5.94; S, 13.62 %. 
Synthesis of compounds (5a-d, 7, 9 and 11) 
General method 
A solution of reactant A (0.01 mole, 4.7 gm) and each of reactant B 
(0.01 mole) in anisole (30 ml) was heated under reflux for 12 h, the 
excess solvent was evaporated in vacuum to the 1/3 of its original 
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volume and cooled then petroleum ether(15 ml) was added. The 
solid product formed was collected by filtration, dried and 
crystallized from the proper solvent, see the following table: 
4-(4-chlorophenyl)-1,3-dioxo-2,9-diphenyl-7-thioxo-9a-(4-methyl-
phenylthio) 2, 3, 3a, 4, 6, 7, 9a, 9b-octaahydro-1H-pyrrolo [3,4-f] 
quinoline-8-carbnitrle (5a) 
Crystallized from ethanol as yellowish crystals (70%); m. p. 233-5oC; 
1H NMR (DMSO-d6) δ=2.22 (s, 3H, tolyl-CH3), 5.3 (d, 1H, CH= 
cyclohexene), 3.6 (br, 1H, NH), 3.5 (t, 1H, cyclo hexene), 3.23(d,1H, 
succinimide), 3.33(t, 1H, succinimide), 6.91-7.56 ppm (m, 18H, Ar-
H); MS (70 eV): m/z = 643 (M+, 16.87), 639(26.8), 576(21.3), 
520(38.5), 470(58), 379(100), 370(50.6), 345(70.56.7), 315(39.4), 
209(17.95), 124(64.55), 89(91.73): Anal. Calcd. for C37H26ClN3O2S2 
(643): C, 68.98; H, 4.07; N, 6.52; S, 9.95. Found: C, 68.99; H, 4.05; N, 




Crystallized from methanol as brown crystals (50%); m. p. 222-4oC; 
1H NMR (DMSO-d6) δ =2.22 (s, 3H, tolyl-CH3), 3.7(S,3H, OCH3), 5.3 (d, 
1H, CH= cyclohexene), 3.6 (br, 1H, NH), 3.5 (t, 1H, cyclohexene), 
3.25(d,1H, succinimide), 3.31(t, 1H, succinimide), 7.14-7.56 ppm (m, 
17H, Ar-H); MS (70 eV): m/z = 674 (M++1, 7.4), 546(4.4), 470(73.5), 
379(82.4), 289 (38.2), 235(22), 203(100), 133(61.8), 90(35.3), 
51(75); Anal. Calcd. for C38H28ClN3O3S2 (673): C, 67.69; H, 3.71; N, 
6.19; S, 9.45. Found: C, 67.70; H, 3.73; N, 6.21; S, 9.47 %. 
  
Reactants A  Reactants B Products 
3 4a (N-phenylmaleimide)  5a 
3 4b (N-4-methoxyphenylmaleimide) 5b 
3 4c (N-4-chlorophenylmaleimide) 5c 
3 4d (2-chloro-5-nitrophenylmaleimide) 5d 
3 6 (Ethyl acrylate) 7 
3 8 (Methyl methacrylate) 9 




f] quinoline-8-carbnitrle (5c)  
Crystallized from petroleum ether and methanol as yellow crystals 
(60%); m. p. 122-5oC; 1H NMR (DMSO-d6) δ =2.23 (s, 3H, tolyl-CH3), 
5.3 (d, 1H, CH= cyclohexane), 3.2 (br, 1H, NH), 3.46 (t, 1H, 
cyclohexane), 3.23(d,1H, succinimide), 3.33(t, 1H, succinimide), 7.00-
7.63 ppm (m, 17H, Ar-H); MS (70 eV): m/z = 677 (M+, 29), 601(16), 
522(16), 488(22.6), 379 (38.7), 289(80.6), 246(48), 163(32), 127 
(67.7), 55(100): Anal. Calcd. for C37H25Cl2N3O2S2 (677): C, 65.48; H, 
3.71; N, 6.19; S, 9.45. Found: C, 65.49; H, 3.73; N, 6.22; S, 9.46 %.  
2-(2-chloro-4-nitrophenyl)-1,3-dioxo-9-phenyl-7-thioxo-9a-(4-
methylpheny thio)-2,3,3a,4,6,7,9a,9b-octahydro-1H-pyrrolo [3, 4-
f] quinoline-8-carbnitrle (5d) 
Crystallized from petroleum ether and methanol as pale yellow 
crystals (55%); m. p. 162-4C; 1H NMR (DMSO-d6) δ =2.3 (s, 3H, tolyl-
CH3), 5.3 (d, 1H, CH= cyclohexane), 3.7 (br, 1H, NH), 3.5 (t, 1H, 
cyclohexane), 3.29(d,1H, succinimide), 3.33(t, 1H, succinimide), 
6.89-7.79 ppm (m, 16H, Ar-H); MS (70 eV): m/z = 723 (M++1, 0.02), 
662(1.42), 601(1.76), 574(20.69), 568(9), 470(23.56), 379 (23.67), 
347(100), 348(90), 314(39), 279(22), 156(38.45), 91(6.24): Anal. 
Calcd. for C37H22Cl2N4O4S2 (722): C, 61.41; H, 3.41; N, 7.74; S, 8.86. 
Found: C, 61.43; H, 3.44; N, 7.77; S, 8.88 %.  
7-(4-chlorophenyl)-3-cyano-4-phenyl-2-thioxo-4a-(4-methyl-
phenylthio)-1,2,4a,5,6,7-hexahydro quinoline-6-caboxylic acid 
ethyl ester (7)  
Crystallized from benzene and methanol as yellow crystals (65%); 
m. p. 294-6oC; 1H NMR (DMSO-d6) δ =2.25 (s, 3H, tolyl-CH3), 5.6 (d, 
1H, CH= cyclohexane), 12.7 (br, 1H, NH), 1.56-1.64 (t, 3H, OCH2CH3), 
3.3(t,1H, cyclohexane), 2.67(q, 1H, cyclohexane), 2.34(d, 2H, 
cyclohexane) 4.16-4.25(q, 2H, OCH2CH3) 6.88-7.43 ppm (m, 13H, Ar-
H); MS (70 eV): m/z = 571 (M++1, 8.32), 376(4.5), 339(29.29), 
276(10.5), 259(7), 207(7.6), 177(17.77), 135(16.24), 124(16.93), 
84(100), 78(55), 55(88.6): Anal. Calcd. for C32H27ClN2O2S2 (570): C, 
67.29; H, 4.76; N, 4.90; S, 11.23. Found: C, 67.30; H, 4.77; N, 4.91; S, 
11.25 %.  
7-(4-chlorophenyl)-3-cyano-6-methyl-4-phenyl-2-thioxo-4a-(4-
methylphenylthio)-1, 2, 4a, 5, 6, 7-hexahydro quinoline-6-
caboxylic acid methyl ester (9)  
Crystallized from petroleum ether and methanol as yellow crystals 
(50%); m. p. 172-4oC; 1H NMR (DMSO-d6) δ =2.25 (s, 3H, tolyl-CH3), 
5.55 (d, 1H, CH= cyclohexene), 12.7 (br, 1H, NH), 2.33(s, 3H, ester-
CH3), 1.3 (S, 3H, cyclohexene-CH3), 3.3(d,1H,cyclohexene), 2.34(d, 
2H, cyclohexene) 6.91-7.44 ppm (m, 13H, Ar-H); MS (70 eV): m/z = 
570 (M+, 0.01), 568(8.3), 540(62.5), 443(100), 348(62.5), 418(70), 
251(87.5), 193 (41.7), 151(8.3), 91(79), 77(12.5); Anal. Calcd. for 
C32H27ClN2O2S2 (570): C, 67.29; H, 4.76; N, 4.90; S, 11.27. Found: C, 
67.30; H, 4.74; N, 4.92; S, 11.27 %.  
7-(4-chlorophenyl)-3-cyano-4-phenyl-2-thioxo-4a-(4-methyl-
phenylthio)-1, 2, 4a, 7,-tetrahydro quinoline-5, 6-dicaboxylic 
acid (11) 
Crystallized from petroleum ether and methanol as brown crystals 
(55%); m. p. 274-6oC; 1H NMR (DMSO-d6) δ =2.22 (s, 3H, tolyl-CH3), 
5.7 (s, 1H, CH-cyclohexene), 12.7 (br, 1H, NH), 13.1 (S, 2H, acid), 
6.93-7.50 ppm (m, 13H, Ar-H); MS (70 eV): m/z = 584 (M+, 0.4), 
573(0.67), 417(1.12), 238(6.38), 227(20), 226(100), 210(22), 181 
(22.37.7), 182(16.79), 140(23.74), 113(5.38), 77(13.26). Anal. Calcd. 
for C31H21ClN2O4S2 (584): C, 63.64; H, 3.62; N, 4.79; S, 10.96. Found: 
C, 63.65; H, 3.61; N, 4.80; S, 10.99 %. 
Biological assays  
Anti-tumor cytotoxicity bioassay in vitro 
HepG2 (liver carcinoma cell line), MCF7 (breast carcinoma cell line) 
and HCT (colon carcinoma cell line) were obtained from the 
Pharmacology Unit, Cancer Biology Department, National Cancer 
Institute, Cairo University, Egypt. Cells were maintained in DMEM 
medium with 10% foetal calf serum, sodium pyruvate, 100 U/ml 
penicillin and 100 µg/ml streptomycin at 37 oC and 5% CO2. 
Potential cytotoxicity of 3 and 5a were tested using the method of 
Skehan et al. [28]. Briefly, 104 cells/well were plated onto 96-well 
dishes overnight before the treatment with the tested compounds to 
allow the attachment of cells to the wall of the plate.  
Different concentrations of each tested compound (0.1, 2.5, 5, 10 
µg/ml) were added to the cell monolayer; triplicate wells were 
used for each individual dose. Monolayer cells were incubated 
with the tested agent(s) for 48h at 37 oC and 5% CO2. At the end of 
the incubation period, the cells were fixed and stained with 
sulforhodamine B dissolved in acetic acid. Unbound stain was 
removed by washing four times with 1% acetic acid and the 
protein-bound dye was extracted with tris-EDTA buffer. 
Absorbance was measured in an ELISA reader.  
The relation between surviving fraction and compound 
concentration was plotted to get the survival curve of each tumor 
cell line and IC50. The concentration of an agent that causes a 50% 
growth inhibition for each tested agent using each cell line was 
obtained from the survival curve.  
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RESULTS AND DISCUSSION  
Chemistry 
The activity of the methyl group attached to the pyridine ring in 6-
methyl-4-phenyl-2-thioxo-5-(4-methylphenylthio)-1,2-dihydro-pyri-
dine-3-carbonitrile (1), which was prepared according to the 
previously reported procedure [28] was tested via its reaction with 
4-chlorobenzaldehyde in ethanol in presence of piperidine to give 
the corresponding ylidene derivative 6-[2-(4-chlorophenyl) viny]-4-
phenyl-5(4-methylphenylthio)-2-thioxo-1,2-di hydro pyridine-3-
carbonitrile (3). A solid evidence for the structure was achieved via 
study of the 1H NMR (DMSO-d6) δ=2.28 (s, 3H, tolyl-CH3), 4.14 (br, 
1H, NH), 6.74-7.49 ppm (m, 15H, Ar-H and CH=CH) and MS (70 eV): 
m/z = 471 (M++1, 8.55), 470(M+, 100). 
The new diene system found in compound 3 stimulated the interest 
to its involvement in a series of dipolar cycloaddition reaction 
leading to an additional number, otherwise difficult obtainable, new 
heterocyclic derivatives from quinolone and pyrrole quinoline which 
are required for biological activity studies.  
A series of N-arylmaleimides 4a-d was refluxed in anisol with 3 to 
yield some new adducts from pyrroloquinole bearing the 
biologically active moiety (-CONArCO-) in addition to other latent 
functional substituent which make then excellent candidates for 
both biological studies as well as further chemical transformation.  
Thus, compound 3 reacted with N-phenyl maleimide (4a) to yield 
pyroloquinoline with molecular formula C37H22ClN3O2S2 which 
represent the total summation of molecular formula of both 3 and 
4a. The mass spectrum gave m/z = 643 (M+, 16.87) which is exactly 
the mass required for the assigned formula and 1H NMR showed the 
following signals: δ=2.22 (s, 3H, tolyl-CH3), 5.3 (d, 1H, CH= 
cyclohexene), 3.6 (br, 1H, NH), 3.5 (t, 1H, cyclohexene), 3.23(d,1H, 
succinimide), 3.33(t, 1H, succinimide),. This compound could be 
formulated as 4-(4-chlorophenyl)-1,3-dioxo-2,9-diphenyl-7-thioxo-
9a-(4-methyl phenyl thio)-2,3,3a,4,6,7,9a,9b-octaahydro-1H-pyrrolo 
[3,4-f]quinoline-8-carbnitrle (5a) (c. f. Experimental Part).  
In the same manner, compound 3 reacted with N-4-
methoxyphenylmaleimide (4b) to give the corresponding adduct 4-(4-
chlorophenyl)-2-(4-methoxyphenyl)-1,3-dioxo-9-phenyl-7-thioxo -9a-
(4-methylphenylthio)-2,3,3a4,6,7,9a,9b-octahydro-1H-pyrrolo [3,4-f] 
quinoline-8-carbnitrle (5b) with molecular formula C38H28ClN3O3S2. 
The structure was confirmed via 1H NMR that showed methoxy group 
at δ = 3.7 (S, 3H, OCH3), and mass spectrum m/z = 674 (M++1, 7.4). and 
also, compound 3 reacted with N-4-chlorophenylmaleimide (4c) to 
obtain 2,4-bis-(4-chlorophenyl)-1,3-dioxo-9-phenyl-7-thioxo-9a-(4-
methylphenylthio)-2,3,3a, 4,6,7, 9a, 9b-octahydro-1H-pyrrolo [3,4-f] 
quinoline-8-carbnitrle (5c).  
The structure of the compound was confirmed via mass spectrum 
m/z = 677 (M+, 29). Reaction of compound 3 with 2-chloro-5-nitro 
phenyl maleimide (4d) gave 2-(2-chloro-4-nitrophenyl)-1,3-dioxo-9-
phenyl-7-thioxo-9a-(4-methyl-phenylthio)-2,3,3a,4,6,7,9a,9b- octa -
hydro-1H-pyrrolo[3,4-f] quinoline-8-carbnitrile (5d). The 
structure was established based on 1H NMR as follows: (DMSO-d6) 
δ =2.23 (s, 3H, tolyl-CH3), 5.3 (d, 1H, CH= cyclohexane), 3.7 (br, 1H, 
NH), 3.5 (t, 1H, cyclohexane), 3.29(d,1H, succinimide), 3.33(t, 1H, 
succinimide), 6.89-7.79 ppm (m, 16H, Ar-H); MS (70 eV): m/z = 





Compound 3 reacted with ethyl acrylate (6) in anisole to yield the 
corresponding 1:1 adduct 7-(4-chlorophenyl)-3-cyano-4-phenyl-2-
thioxo-4a-(4-methylphenylthio)-1,2,4a,5,6,7-hexa hydroquinoline-6-
caboxylic acid ethyl ester (7). The structure of this compound was 
confirmed by 1H NMR (DMSO-d6) δ =2.25 (s, 3H, tolyl-CH3), 5.6 (d, 
1H, CH= cyclohexane), 12.7 (br, 1H, NH), 1.56-1.64 (t, 3H, OCH2CH3), 
3.3(t,1H, cyclohexane), 2.67(q, 1H, cyclohexane), 2.34(d, 2H, 
cyclohexane) 4.16-4.25(q, 2H, OCH2CH3) ppm (m, 13H, Ar-H); in 
addition to MS (70 eV), m/z = 571 (M++1, 8.32), 376(4.5), 
339(29.29),). Analogously, methyl methacrylate (8) reacted with 
compound 3 and gave 7-(4-chlorophenyl) 3-cyano-6-methyl-4-
phenyl-2-thioxo-4a-(4-methylphenylthio)-1, 2, 4a, 5, 6, 7-hexahydro 
quin oline-6-caboxylic acid methyl ester (9) and structure was 
confirmed by 1H NMR which showed three methyl groups at δ =2.25 
(s, 3H, tolyl-CH3), 2.33(s, 3H, ester-CH3), 1.3 (S, 3H, cyclohexene-CH3) 
and mass spectrum MS (70 eV): m/z = 570 (M+, 0.01). The reaction 
of compound 3 with acetylene dicarboxylic acid (10) afforded 
compound 7-(4-chloro phenyl)-3-cyano-4-phenyl-2-thioxo-4a-(4-
methylphenylthio)-1, 2, 4a, 7-tetrahydro quinoline-5, 6-dicaboxylic 
acid (11). (c. f. Experimental Part). A solid evidence for the structure 
was achieved via 1H NMR 5.7 (s, 1H, CH-cyclohexene), 12.7 (br, 1H, 
NH), 13.1 (S, 2H, acid) and study of the mass spectrum of this 
reaction product which gave m/z = 584 (M+, 0.4). (c. f. Experimental 
Part).
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Two new compounds numerically labeled with 3 and 5a were 
preliminarily screened for their in vitro antiproliferative activity against 
human liver cancer (HepG2), human colon cancer (HCT) and human 
breast cancer (MCF-7) cell lines at different concentration. Doxorubicin, 
which is one of the most effective anticancer agents, was used as a 
reference drug (fig. 1-3). Results from the fig. indicated that these two 
compounds displayed moderate to good anticancer activity on the cell 
lines. Against MCF-7 cell line, two compounds showed good anticancer 
effect and compounds 3 with chalcone moiety on pyridine 2(1H) thione 
ring displayed better anticancer activity than compound 5a with 
pyrroloquinoline. and this agreement with the literature that presence of 
chalcone moiety in compound give broad spectrum biological activities 
including anticancer effect [29].  
However, these compounds showed the poor anticancer effect on both 
HepG2 and cell lines. In the case of HCT compound 3 showed more 
potent activity than compound 5a may also be  due to present 
chalcones that exhibit cytotoxicity against a number of cell lines from a 
wide range of tumors, mainly colon cancer [30]. on contrast, in the 
case of HepG2 cell line, the results indicated that compounds 5a 
showed more potent activity than compound 3 because of the 
presence of pyrroloquinoline moiety natural sources with a good effect 
on hepatocarcinoma [31, 32] 
 
 
Fig. 1: Percentage viability of MCF-7, HepG2 and HCT cells after 
treatment with positive control (Doxorubicin) (0.1, 2.5, 5, 10 
µg/ml) for 48 h prior to MTT assay to determine the potential 
anticancer effect. The calculated IC50 values of MCF-7, HepG2 
and HCT were 2.97, 3.37 and 3.37 μg/ml, respectively 
 
Fig. 2: Percentage viability of MCF-7, HepG2 and HCT cells after 
treatment with compound 3 (0.1, 2.5, 5, 10 µg/ml) for 48 h prior 
to MTT assay to determine potential anticancer effect. The 
calculated IC50 values of MCF-7, HepG2 and HCT were 9.8, 22.8 
and 20.2 μg/ml, respectively 
 
 
Fig. 3: Percentage viability of MCF-7, HepG2 and HCT cells after 
treatment with compound 5a (0.1, 2.5, 5, 10 µg/ml) for 48 h 
prior to MTT assay to determine potential anticancer effect. The 
calculated IC50 values of MCF-7, HepG2 and HCT were 11.2, 20.1 
and 24.6 μg/ml, respectively 
 
CONCLUSION 
New quinoline and pyrroloquinoline derivatives were synthesized 
starting with 6-methyl-4-phenyl-2-thioxo-5-(4-methylphenylthio)-
1,2-dihydropyridine-3-carbonitrile. Two new compounds 3 and 5a 
were tested for their in vitro antiproliferative activity against MCF-7, 
HepG2 and HCT cancer cell lines. The result showed that compound 
Mohamed et al. 
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3 exhibited more potent antiproliferative activity than compound 5a 
in the case of MCF-7 and HCT.  
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